Breast cancer and cancer stem cells: a mini-review

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00179906%3A_____%2F14%3A10281272" target="_blank" >RIV/00179906:_____/14:10281272 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11150/14:10281272

Výsledek na webu

<a href="http://www.tumorionline.it/r.php?v=1636&a=17886&l=26486&f=allegati/01636_2014_04/fulltext/01-Filipova%20363-369.pdf" target="_blank" >http://www.tumorionline.it/r.php?v=1636&a=17886&l=26486&f=allegati/01636_2014_04/fulltext/01-Filipova%20363-369.pdf</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1700/1636.17886" target="_blank" >10.1700/1636.17886</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Breast cancer and cancer stem cells: a mini-review

Popis výsledku v původním jazyce

Breast cancer is the most common type of malignant disease in women worldwide. In developing countries the past few years have sustained an increasing incidence of this type of cancer. Currently, breast cancer is the second leading cause of death due tocancer in women. In 2008 alone it was diagnosed in more than 1 million patients and each year the number of breast cancer-related deaths is estimated to be ~450,000. The mortality rate in breast cancer patients has been decreasing over the years thanks to the development of early diagnostic methods and more effective treatments. But despite the new advances in cancer diagnosis and treatment, the risk of recurrence and metastasis is ever present. It has been theorized that cancer stem cells are involvedin the process of tumor growth and metastases. Due to their self-renewing and differentiation capabilities, they are now considered the underlying factor in tumor recurrence and the main reason for therapy resistance. Therefore, the chara

Název v anglickém jazyce

Breast cancer and cancer stem cells: a mini-review

Popis výsledku anglicky

Breast cancer is the most common type of malignant disease in women worldwide. In developing countries the past few years have sustained an increasing incidence of this type of cancer. Currently, breast cancer is the second leading cause of death due tocancer in women. In 2008 alone it was diagnosed in more than 1 million patients and each year the number of breast cancer-related deaths is estimated to be ~450,000. The mortality rate in breast cancer patients has been decreasing over the years thanks to the development of early diagnostic methods and more effective treatments. But despite the new advances in cancer diagnosis and treatment, the risk of recurrence and metastasis is ever present. It has been theorized that cancer stem cells are involvedin the process of tumor growth and metastases. Due to their self-renewing and differentiation capabilities, they are now considered the underlying factor in tumor recurrence and the main reason for therapy resistance. Therefore, the chara

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FD - Onkologie a hematologie

OECD FORD obor

—

Projekt

<a href="/cs/project/EE2.3.30.0022" target="_blank" >EE2.3.30.0022: Podpora vytváření, rozvoje a mobility kvalitních výzkumně-vývojových týmů na Univerzitě Karlově</a><br>

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2014

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Tumori

ISSN

0300-8916

e-ISSN

—

Svazek periodika

100

Číslo periodika v rámci svazku

4

Stát vydavatele periodika

IT - Italská republika

Počet stran výsledku

7

Strana od-do

363-369

Kód UT WoS článku

000348335300001

EID výsledku v databázi Scopus

—